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Forty-six benign and malignant tum ours and tum our-like lesions o f the thyroid were analysed for 
m icrosatellite instability (MI) at eight loci, m apping to four different chrom osom es, 7 lesions (15%) 
displayed MI at one or more loci, including 2/13 nodular goitres, 2/15 follicular adenom as, 2/12 
papillary carcinom as and 1/4 follicular carcinom as. Two benign and one m alignant lesion  am ong  
the seven unstable cases exhibited this phenotype at three or m ore loci. We found no m utations in  
the m ism atch  repair gene, hMSH2, in  the seven affected cases, after screening all the exons by 
CDGE m utation analysis. At variance with the data on record, these results indicate that, despite  
being relatively infrequent, MI does occur not only in thyroid carcinom as but also in benign lesions 
(goitres and follicular adenomas of the thyroid). ©  1997 Elsevier Science Ltd. All rights reserved. 
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INTRODUCTION
M i c r o  s a t e l l i t e  i n s t a b i l i t y  (MI) is a genetic phenomenon 
manifested by shifts in the electrophoretic mobility of micro­
satellite repeat fragments. Mutations (generally small del­
etions or insertions) occurring during replication remain 
unrepaired and result in novel alleles. MI was first reported 
in sporadic and hereditary non-polyposis colorectal carci­
noma (HNPCC) [1-3] and thereafter associated with inacti­
vating mutations in the human DNA mismatch repair genes 
HMSH2, hM LH  1 , hPM Sl and hPMS2 [4-8]. It was further 
shown that cells harbouring such mutations were mismatch 
repair deficient and hypermutable [9* 10].
The prevalence of MI varies greatly in HNPCC-related 
sporadic carcinomas (colon* stomach, pancreas, ovary and 
endometrium) [1-3, 11-17], as well as in other types of 
tumours such as breast, lung and prostate carcinomas [12, 
14, 18-22]. There also appears to be large variation in the 
prevalence of MI in precancerous lesions of different organs 
[23-26], thus leading to divergent assumptions on the tim­
ing of occurrence of this type of genomic instability in 
tumorigenesis [24, 26, 27].
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A limited number of thyroid carcinomas have been ana­
lysed for MI. Nine tumours reported by Vermiglio and as­
sociates did not exhibit MI, whereas thyroid carcinomas 
from 3 patients with multiple primary cancers did show this 
phenotype [29], In addition, MI has not been reported, to 
the best of our knowledge, in any other benign or malignant 
endocrine tumour. In order to evaluate furtlier this phenom­
enon in the thyroid, 46 lesions were analysed for instability 
at eight micro satellite loci.
MATERIALS AND METHODS
Tumour samples (n = 46)
In each case, fresh tissue samples from thyroid nodules 
were immediately snap frozen in liquid nitrogen and stored 
at —70°C until use. When available, D N A  from normal 
parenchyma adjacent to the lesions (n = 18) was used as a 
constitutional control, otherwise, we used corresponding 
peripheral blood D N A  (77 = 28). High-molecular-weight 
DNA was isolated using standard methods [30]. 
Classification of the lesions was made according to 
Hedinger and associates [31] and Rosai and associates [32] 
into nodular goitre (w -1 3 ) , follicular adenoma (7? = 1 5 ),  
papillary carcinoma (w = 12), follicular carcinoma (n = 4) 
and poorly differentiated carcinoma (n = 2). There was no
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Table 1 , Thyroid lesions zvith microsatellixe instability
Cases Lesion
Microsatellite markers
Number*D1S196 D1S103 D5S346 D2S102 CTLA4 D5S82 D16S265
1 NG — — — — MI — 1/8
2 NG M I — — M I - - MI — 3/8
3 FA MI MI MI M I — — — 4/8
4 FA — — — — — MI — 1/8
5 PC — — — — — MI — 1/8
6 PC MI MI MI ND MI MI MI 6/7
7 FC — — — — MI 1/8
*Loci with micro satellite instability/loci analysed.
NG, nodular goitre; FA* follicular adenoma; PC, papillary carcinoma; FC, follicular carcinoma; MI, microsatellite instability; ND> not 
determined; - , normal homozygote or heterozygote and unchanged in tumours.
history of familial cancer syndromes or multiple primary 
cancers in any of the 46 patients.
Microsatellite marker analysis
Paired samples of tumour and normal control DNA were 
amplified by PCR (polymerase chain reaction) at the following 
eight loci containing dinucleotide repeat sequences 
(chromosomal location in parentheses): D1S103 (lq)* 
D1S196 (lq )5 D2S102 (2q)* CTLA4 (2q)* D5S346 (5q)> 
D5S82 (5q), D16S265 (16q) and D16S301 (I6q). PCR was 
performed in 25 |il volumes of a mixture containing 10 mM 
Tris-HCl (pH 8.0), 50 mM of KC1* 1.5 mM MgCl2* 100 
of each deoxynucleotide triphosphate except dCTP* 10 (iM of 
dCTP* 1 \xCi of [o:-32P] dCTP* 0.4 jaM of each primer* 0.75 
units of Tag D N A  polymerase* and 30-50 ng of genomic 
DNA. Thirty cycles of 94 °C for 1 min* 55 °C for 1 min* and 
72°C for 1.75 min were performed* with an initial dénatura­
tion step of 94°C for 5 min and a final extension step of 72&C 
for 10 min using a Perkin-Elmer 9600 GeneAmp PCR 
System. PCR reaction products were diluted 1:1 with a load­
ing buffer (98% formamide* 0.1% xylene cyanol FF, 0.1% 
bromophenol blue* and 10 mM EDTA [pH 8,0]) and then de­
natured for 5 min at 95°C. Subsequently* 2 [i\ of this solution 
were electrophoresed in 6% polyacrylamide gels containing 7 
M urea and 32.5% foxmamide for 2-3 h at 60 W .  After electro­
phoresis* gels were fixed in 10% acetic acid* washed* dried and 
exposed to X-ray field for 12-24 h. All scorings were made 
independently by two observers. According to Thibodeau and 
associates [3]* genetic alterations involving the gain or loss of 
two or more repeat units are classified as Type I and alterations 
of one repeat unit as Type II. Eight loci were analysed per case 
and* for the sake of simplicity* a tumour was considered posi­
tive (MI) when at least one locus displayed a different mobility 
band. This option does not mean we belittle the existence of 
aetiopathogenic differences between cases with single-repeat 
slippage at just one locus and cases with slippage at several 
loci. Such differences are taken into account in the comparison 
of the different groups (see Results and Table 1). All RER+ 
loci were confirmed by a new PCR and electrophoretic run.
hMSH2 mutation analysis
All 16 exons of hMSH2  were screened for mutations 
using constant dénaturant gel electrophoresis (CDGE) [33]. 
The separation principle of CDGE is based on the unique 
melting behaviour of each D N A  fragment. The detailed 
procedure for such analysis of HMSH2 has been recently 
published [34]. Briefly* theoretical melting profiles were cal­
culated for all exons* followed by primer design using 
MacMelt 1.0 (MedProbe A/S) and OLIGO (National 
Biosciences) computer programs. Template DNAs were 
amplified by PCR* and the products separated by CDGE 
(D-GENE system* BioRad). If a mutation is indicated by 
CDGE, sequencing of the affected exon will identify the 
exact position of the changed base(s). By using the con­
ditions described by Borresen and associates [34]* it was 
estimated that approximately 65% of all mutations will be 
detected within the analysed fragments.
RESULTS
The results are summarised in Tables 1 and 2. Seven of the 
46 thyroid lesions displayed MI at one or more loci (Table 1). 
Among these* there were two nodular goitres and two follicu­
lar adenomas* thus leading to an overall MI prevalence of 
14.3% in the 28 benign lesions (Table 2). Two papillary car­
cinomas and a follicular carcinoma displayed MI* thus lead­
ing to a MI prevalence of 16.7% in the 18 carcinomas.
Three out of the seven lesions displayed MI at three or 
more loci (a nodular goitre (Figure 1))* a follicular adenoma 
and a papillary carcinoma (Figure 2)* whereas the remaining 
four lesions showed MI at a single locus (Table 1).
Cases 1* 4 and 7* with MI at a single locus* displayed 
Type II alterations* whereas case 5* also with one altered 
locus* displayed a Type I alteration (see Materials and 
Methods). Cases 2 and 3* with three and four unstable loci 
respectively* displayed both Type I and Type II alterations. 
Case 6 displayed Type I alterations at all affected loci.
Both papillary carcinomas with MI displayed discrete to 
moderate lymphoid infiltration which could also be observed 
in most of the papillary carcinomas without ML 
Comparison of the histological features of other lesions with 
MI with those of their non-unstable counterparts did not 
disclose any notable difference.
Among the seven microsatellite unstable tumours* no 
aberrantly migrating bands were observed by CDGE of the 
16 hMSH2  exons* and thereby no mutations were indicated.
Table 2 . Frequency of microsatellite instability in thyroid lesions
Diagnosis (n)
Nodular goitre (13) 2 (15.4%) 1 (7.6%)
Follicular adenoma (15) 2 (13.3%) 1 (6 .6%)
Papillary carcinoma (12) 2 (16.7%) 1 (8.3%)
Follicular carcinoma (4) 1 (25.0%) 0 (0%)
Poorly differentiated carcinoma (2) 0 (0%) 0 (0%)
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Figure 1, Case 2: This nodular goitre displayed MI at three 
loci. Haematoxylin and eosin. Inset: PCR amplification of 
locus D5S82 showing Type II alteration (left lane, normal
thyroid; right lane, goitre). Magnification xl25.
Loss of heterozygosity was found at DIS 103 and D IS 196 in 
a follicular adenoma and a follicular carcinoma, respectively.
DISCUSSION
Two of the three microsatellite unstable carcinomas were 
only affected at one out of eight loci, implying that these 
two cases could have been scored as negative if fewer loci 
had been analysed. Therefore, the absence of MI in thyroid 
carcinomas reported by Vermiglio and associates [28] prob­
ably reflects the limited number of analysed markers and 
the small size of their series.
The three thyroid carcinomas with MI reported by Horii 
and associates [29] were observed in a series of patients 
with multiple primary cancers, and are thereby not directly 
comparable to those of our series. The tumours of the 
present study were from patients with no history of familial 
cancer nor evidence of other primary cancers. Taking our 
results together with those of Vermiglio and associates [28], 
one may conclude that the prevalence of MI in thyroid car­
cinomas, outside the context of multiple primary cancers, 
lies below the values reported for HNPCC-related sporadic 
carcinomas [1-3, II , 12, 14, 16, 17].
The discrepant prevalences of MI in thyroid carcinomas, 
prostatic carcinomas [18, 19], and breast carcinomas [20, 
2 1 ], rules out the possibility of establishing a close relation­
V* t .
Figure 2» Case 6: This papillary carcinoma displayed MI at 
six loci. Haematoxylin and eosin. Inset: PCR amplification of 
locus CTLA4 showing Type I alteration (left lane, normal thyr­
oid; right lane, papillary carcinoma). Magnification xl25.
ship between hormone-dependent tumours in general and 
prevalence o f MI.
MI has been detected in lesions of ulcerative colitis, 
regardless of the presence of dysplasia [35], Brentnall and 
associates proposed that MI in this setting could result from 
saturation o f the DNA repair mechanisms due to the stress 
of chronic inflammation. It is unlikely that such a mechan­
ism is operative in the unstable tumours of the present 
series, namely in the goitre cases, since none of them dis­
played signs of inflammation. The occurrence of MI at one 
or few loci may also represent a random event [36]. This 
possibility cannot be definitely ruled out especially in those 
cases exhibiting single locus alterations. The same does not 
hold true, however, for thyroid lesions with instability at 
multiple loci— as many as six out of seven unstable loci 
were observed in one of our cases. We do not know if  the 
use of tri- and tetranucleotide markers would lead to a 
higher number of altered loci in thyroid tumours, since it is 
known that different patterns of alterations of short tandem 
repeats are found in different types of tumours [20, 37-39].
The finding of a subset of benign thyroid tumours and 
tumour-like lesions displaying MI at several loci suggests 
that MI can be an early event in thyroid tumorigenesis, thus 
fitting well with Loeb’s hypothesis [40] and with the obser­
vation of MI in some precancerous dysplasias of the 
stomach [24], adenomas and/or dysplasias of the colon [25- 
27], and Barrett's metaplasia of the oesophagus [23]. 
Moreover, the occurrence of MI at several loci in a nodular 
goitre fits with die concept that at least some of the nodules 
of the so-called adenomatous goitres appear to be neoplastic 
rather than hyperplastic [41].
We found a similar prevalence of MI in benign lesions 
and carcinomas o f the thyroid, both when the comparison 
concerns the cases with affected loci, regardless of their 
number, and when it is restricted to cases with several 
affected loci, but a larger series is necessary to confirm this 
finding, which contrasts with the usually much lower fre­
quency of MI in benign lesions than in their malignant 
counterparts in several organs [23, 24, 26]. In colorectal 
tumours, the majority of unstable adenomas are affected at 
a single locus, whereas more than half of the unstable carci­
nomas show novel alleles at several loci [13, 26], suggesting 
that these changes accumulate during tumour growth.
We cannot rule out the putative involvement of DNA poly­
merases at least in the cases presenting alterations at a single 
locus, since it has been reported that mutations of DNA poly­
merases may interfere with poly(GT) tract stability [42], 
whereas the occurrence of MI at multiple loci suggests the 
existence of abnormalities of D N A  mismatch repair genes 
[42, 43]. Six o f seven tumours showed novel alleles at the 
D5S82 locus, suggesting that this locus is highly unstable.
The mismatch repair gene HMSH2 is apparently not 
mutated in any o f the microsatellite unstable cases of our 
series. This may reflect the fact that thyroid carcinoma is 
not part of HNPCC; the size of the series is, however, too 
small to allow any definitive conclusion on this issue and it 
is estimated that only approximately 65% of all mutations 
of hMSH2  will be detected within the analysed fragments 
under the conditions we have used [34]. Additional tumours 
need to be collected for MI in order to study further 
hM SH 2 and to search for mutations in other DNA  
mismatch repair genes to see if we can find in thyroid 
pathology, as in other systems, a relationship between MI
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and abnormalities of at least one mismatch repair gene [34, 
44].
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